0.9111
전일 마감가:
$0.9263
열려 있는:
$0.92
하루 거래량:
17,461
Relative Volume:
0.26
시가총액:
$8.28M
수익:
$20.69M
순이익/손실:
$-44.34M
주가수익비율:
-0.1442
EPS:
-6.32
순현금흐름:
$-7.51M
1주 성능:
-4.10%
1개월 성능:
+0.12%
6개월 성능:
+5.94%
1년 성능:
-42.34%
DSS Inc Stock (DSS) Company Profile
명칭
DSS Inc
전화
585-325-3610
주소
200 Canal View Boulevard, Suite 300, Rochester, NY
DSS을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
DSS
DSS Inc
|
0.9111 | 8.64M | 20.69M | -44.34M | -7.51M | -6.32 |
![]()
IP
International Paper Co
|
51.36 | 27.51B | 19.90B | 396.00M | -5.00M | 1.17 |
![]()
SW
Smurfit Westrock Plc
|
45.44 | 24.22B | 25.80B | 571.00M | -106.12M | 1.44 |
![]()
AMCR
Amcor Plc
|
9.41 | 22.04B | 13.55B | 769.00M | 674.00M | 0.531 |
![]()
PKG
Packaging Corp Of America
|
201.39 | 18.30B | 8.54B | 861.90M | 528.80M | 9.56 |
![]()
BALL
Ball Corp
|
58.01 | 16.15B | 12.02B | 502.00M | 286.00M | 1.68 |
DSS Inc Stock (DSS) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2020-06-24 | 개시 | Aegis Capital | Buy |
2013-07-22 | 개시 | Dawson James | Buy |
DSS Inc 주식(DSS)의 최신 뉴스
What analysts say about DSS Inc. stockDynamic portfolio growth - Autocar Professional
Is DSS Inc. a good long term investmentUnprecedented profit potential - PrintWeekIndia
What drives Jet.AI Inc. stock priceFree Capital Efficiency Planning - PrintWeekIndia
Is HealthStream Inc. a good long term investmentSuperior stock selection - Autocar Professional
What analysts say about CoreWeave Inc. stockAccelerated profit realization - jammulinksnews.com
DSS Inc. Stock Analysis and ForecastTremendous portfolio expansion - jammulinksnews.com
What drives DSS Inc. stock priceRapid market gains - jammulinksnews.com
What analysts say about Veracyte Inc. stockFree Investment Timing Strategies - jammulinksnews.com
What drives First Mid Bancshares Inc. stock priceFree Stock Market Return Analysis - jammulinksnews.com
Best Infrastructure Stocks AI Driven Portfolio ManagementSuperior capital gains - jammulinksnews.com
Does NIKE Inc. stock pay reliable dividendsHigh Yield Opportunities - Newser
why smtc stock attracts strong analyst attentionDouble Your Capital Alerts - Newser
Why DSS Inc. stock attracts strong analyst attentionFree Exclusive Group - Newser
Why Sleep Number Corporation stock attracts strong analyst attentionDaily Gain Forecast - Newser
How DSS Inc. stock performs during market volatilityLow Volatility High Yield Stocks - Newser
Why The Children s Place Inc. stock attracts strong analyst attentionDaily Breakout Picks - Newser
What makes DSS Inc. stock price move sharplyMassive Upside Selection - Newser
DSS switches auditors to HTL; no disputes with Grassi reported | MS SEC FilingForm FWP - Stock Titan
DSS subsidiary Impact BioMedical to merge with Dr. Ashleys - Investing.com
DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth | DSS Stock News - GuruFocus
DSS reports Q1 EPS (55c) vs. (58c) last year - TipRanks
DSS, Inc. Reports Strong Q1 2025 Financial Results with 28% Revenue Growth and Significant Debt Reduction - Nasdaq
DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth - GlobeNewswire
DSS Delivers Triple Win in Q1 2025: 28% Revenue Jump, $9.5M Asset Sale, and Major Debt Reduction - Stock Titan
The 7 Best Robinhood Stocks Under 2 Dollars To Buy For July 2025 - The Stock Dork
DSS, Inc. Interview To Air On Bloomberg U.S. On The RedChip Money Report® - Barchart.com
Market Watch Highlights: Impact BioMedical Inc (IBO) Ends on an Upturn Note at 0.61 - DWinneX
Daily Turnover | The turnover of Impact BioMedical on 5/2 was $144.03 Million, Ranking 625 - AInvest
Market Resilience: Impact BioMedical Inc (IBO) Finishes Weak at 0.50, Down -2.92 - DWinneX
Sentinel Brokers Company, Inc., a Subsidiary of DSS, Inc., Recei - GuruFocus
Sentinel Brokers Company, Inc., a Subsidiary of DSS, Inc., Receives FINRA Approval to Act as Underwriter and Selling Group Member for Corporate Securities Offerings - The Globe and Mail
Sentinel Brokers Company, Inc., a Subsidiary of DSS, Inc., - GlobeNewswire
DSS Subsidiary Secures FINRA Approval for IPO Underwriting Services | DSS Stock News - Stock Titan
Closing Figures: Impact BioMedical Inc (IBO)’s Positive Finish at 0.42, Up 1.11 - DWinneX
The VA EHR modernization roadmap under the Trump administration - Federal News Network
Insider Activity Roundup: Monday's Top Buys and Sells in US Stocks - Investing.com
DSS, Inc. sells $845,012 in Impact Biomedical stock By Investing.com - Investing.com Canada
DSS, Inc. sells $845,012 in Impact Biomedical stock - Investing.com
12 Industrials Stocks Moving In Friday's After-Market Session - Benzinga
DSS Inc (DSS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):